LEADER 01421nam--2200409---450-
001 990003197980203316
005 20090218143856.0
010   $a978-92-79-09455-2
035   $a000319798
035   $aUSA01000319798
035   $a(ALEPH)000319798USA01
035   $a000319798
100   $a20090218d2008----km-y0itay0103----ba
101   $aeng
102   $aLU
105   $a||||||||001yy
200 1 $aVaccines for humans$eresearch funded by the European Union$fEuropean commission, Directorate Health
210   $aLuxembourg$cOffice for official publications of the European Communities$d2008
215   $a167 p.$cill.$d30 cm
225 2 $aEuropean Research Area$iProject synopses
410  1$12001$aEuropean Research Area$iProject synopses
606 0 $aVaccini$yPaesi della Comunità europea$2BNCF
676   $a614.47
699   $a15.05$bVaccini
710 02$aCommissione europea :$bDirezione generale Ricerca$0542713
801  0$aIT$bsalbc$gISBD
856 4 $uhttp://dx.doi.org/10.2777/84341$4.$zAccesso online
912   $a990003197980203316
951   $aCDE 15.05 (IX)$bCDE 2167$cCDE 15.05$d00151304
959   $aBK
969   $aCDE
979   $aMARIAS$b90$c20090218$lUSA01$h1434
979   $aMARIAS$b90$c20090218$lUSA01$h1437
979   $aMARIAS$b90$c20090218$lUSA01$h1438
979   $aMARIAS$b90$c20140730$lUSA01$h1439
996   $aVaccines for humans$91015056
997   $aUNISA